Company intelligence / Profile preview

Infensa Bioscience

Brisbane, Queensland, Australia

Ownership: Private
Employees: ~13
Development stage: Preclinical

Overview

Infensa Bioscience develops first-in-class peptide therapeutics derived from Australian funnel web spider venom. Their lead candidate, Hi1a, inhibits ASIC1a channels to protect heart and brain cells from ischemic damage during heart attacks or strokes. Preclinical studies show Hi1a can selectively protect injured tissue without affecting healthy cells. The company has raised significant funding to advance into human clinical trials targeting acute cardiovascular events where no current drugs exist to prevent organ damage.

Therapeutic areas: Cardiovascular
Modalities: Peptides (notably venom-derived peptides)
Industry: Biotech

Drug pipeline

1 asset

IB409

Unknown

Partnerships

Brisbane Economic Development Agency’s MedTech Global Accelerator program supports the company with access to partnerships and capitalcollaborations with University of Queensland researchers.

Beyond the preview

Go deeper on Infensa Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infensa Bioscience.

Explore the full profile